{"id":"W4399926328","doi":"10.1016/j.esmoop.2024.103537","title":"37MO Dostarlimab plus chemotherapy in primary advanced or recurrent endometrial cancer (pA/rEC) in the RUBY trial: Overall survival (OS) by MMR status and molecular subgroups","year":2024,"lang":"en","type":"article","venue":"ESMO Open","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"GlaxoSmithKline","keywords":"Endometrial cancer; Oncology; Medicine; Internal medicine; Overall survival; Chemotherapy; Gynecology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00154454,0.0005971089,0.001700918,0.0002180081,0.0002476143,0.0005213785,0.0003565938,0.0005703687,0.002334649],"category_scores_gemma":[0.0009206692,0.0002908502,0.001485296,0.0002268268,0.0003624622,0.0003447454,0.0003889969,0.001399021,0.0003341795],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004878506,"about_ca_system_score_gemma":0.0008989409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008872228,"about_ca_topic_score_gemma":0.003393058,"domain_scores_codex":[0.9994048,0.0003868658,0.00003362618,0.00005755442,0.00003857622,0.00007857137],"domain_scores_gemma":[0.9997274,0.00006404957,0.00006712222,0.00003029963,0.00001457832,0.00009655521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8652479,0.002742292,0.005998053,0.001162656,0.001988118,0.0001065995,0.0001457052,0.001352149,0.009639414,0.0002979571,0.002293546,0.1090256],"study_design_scores_gemma":[0.6896343,0.2597884,0.03131226,0.000241147,0.003959537,0.0003976881,0.000112833,0.001514024,0.002906721,0.0007156403,0.009378259,0.00003925158],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854453,0.01090535,0.000330104,0.0004875403,0.0001043075,0.0007665281,0.0005684948,0.00005440521,0.001338009],"genre_scores_gemma":[0.9913966,0.003140061,0.001127748,0.0005339088,0.0001373317,0.001011473,0.0008476794,0.00001497639,0.001790264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002334649,"threshold_uncertainty_score":0.008168399,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03420991255425919,"score_gpt":0.3512152869362682,"score_spread":0.317005374382009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}